216 related articles for article (PubMed ID: 28035364)
1. CYR61/CCN1 stimulates proliferation and differentiation of osteoblasts in vitro and contributes to bone remodeling in vivo in myeloma bone disease.
Liu H; Peng F; Liu Z; Jiang F; Li L; Gao S; Wang G; Song J; Ruan E; Shao Z; Fu R
Int J Oncol; 2017 Feb; 50(2):631-639. PubMed ID: 28035364
[TBL] [Abstract][Full Text] [Related]
2. CCN1 stimulated the osteoblasts via PTEN/AKT/GSK3β/cyclinD1 signal pathway in Myeloma Bone Disease.
Yan S; Liu H; Liu Z; Peng F; Jiang F; Li L; Fu R
Cancer Med; 2020 Jan; 9(2):737-744. PubMed ID: 31769620
[TBL] [Abstract][Full Text] [Related]
3. CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease.
Johnson SK; Stewart JP; Bam R; Qu P; Barlogie B; van Rhee F; Shaughnessy JD; Epstein J; Yaccoby S
Blood; 2014 Sep; 124(13):2051-60. PubMed ID: 25061178
[TBL] [Abstract][Full Text] [Related]
4. CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance.
Zhao G; Huang BL; Rigueur D; Wang W; Bhoot C; Charles KR; Baek J; Mohan S; Jiang J; Lyons KM
J Bone Miner Res; 2018 Jun; 33(6):1076-1089. PubMed ID: 29351359
[TBL] [Abstract][Full Text] [Related]
5. CCN1, a candidate target for zoledronic acid treatment in breast cancer.
Espinoza I; Liu H; Busby R; Lupu R
Mol Cancer Ther; 2011 May; 10(5):732-41. PubMed ID: 21393426
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cells.
Dotterweich J; Ebert R; Kraus S; Tower RJ; Jakob F; Schütze N
Cell Commun Signal; 2014 Jun; 12():36. PubMed ID: 24965524
[TBL] [Abstract][Full Text] [Related]
7. Matrix-bound Cyr61/CCN1 is required to retain the properties of the bone marrow mesenchymal stem cell niche but is depleted with aging.
Marinkovic M; Dai Q; Gonzalez AO; Tran ON; Block TJ; Harris SE; Salmon AB; Yeh CK; Dean DD; Chen XD
Matrix Biol; 2022 Aug; 111():108-132. PubMed ID: 35752272
[TBL] [Abstract][Full Text] [Related]
8. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells.
Si W; Kang Q; Luu HH; Park JK; Luo Q; Song WX; Jiang W; Luo X; Li X; Yin H; Montag AG; Haydon RC; He TC
Mol Cell Biol; 2006 Apr; 26(8):2955-64. PubMed ID: 16581771
[TBL] [Abstract][Full Text] [Related]
9. Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma.
Dobroff AS; Wang H; Melnikova VO; Villares GJ; Zigler M; Huang L; Bar-Eli M
J Biol Chem; 2009 Sep; 284(38):26194-206. PubMed ID: 19632997
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation.
Schutze N; Noth U; Schneidereit J; Hendrich C; Jakob F
Cell Commun Signal; 2005 Mar; 3(1):5. PubMed ID: 15773998
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease.
Eda H; Santo L; Wein MN; Hu DZ; Cirstea DD; Nemani N; Tai YT; Raines SE; Kuhstoss SA; Munshi NC; Kronenberg HM; Raje NS
J Bone Miner Res; 2016 Jun; 31(6):1225-34. PubMed ID: 26763740
[TBL] [Abstract][Full Text] [Related]
12. Cysteine-rich protein 61 regulates adipocyte differentiation from mesenchymal stem cells through mammalian target of rapamycin complex 1 and canonical Wnt signaling.
Yang Y; Qi Q; Wang Y; Shi Y; Yang W; Cen Y; Zhu E; Li X; Chen D; Wang B
FASEB J; 2018 Jun; 32(6):3096-3107. PubMed ID: 29401606
[TBL] [Abstract][Full Text] [Related]
13. CCN1/Cyr61 Is Required in Osteoblasts for Responsiveness to the Anabolic Activity of PTH.
Zhao G; Kim EW; Jiang J; Bhoot C; Charles KR; Baek J; Mohan S; Adams JS; Tetradis S; Lyons KM
J Bone Miner Res; 2020 Nov; 35(11):2289-2300. PubMed ID: 32634285
[TBL] [Abstract][Full Text] [Related]
14. Tensile stress stimulates the expression of osteogenic cytokines/growth factors and matricellular proteins in the mouse cranial suture at the site of osteoblast differentiation.
Ikegame M; Tabuchi Y; Furusawa Y; Kawai M; Hattori A; Kondo T; Yamamoto T
Biomed Res; 2016; 37(2):117-26. PubMed ID: 27108881
[TBL] [Abstract][Full Text] [Related]
15. CCN1: a sticky issue in myeloma.
Roodman GD
Blood; 2014 Sep; 124(13):2006-8. PubMed ID: 25258135
[No Abstract] [Full Text] [Related]
16. Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts.
Faict S; Muller J; De Veirman K; De Bruyne E; Maes K; Vrancken L; Heusschen R; De Raeve H; Schots R; Vanderkerken K; Caers J; Menu E
Blood Cancer J; 2018 Nov; 8(11):105. PubMed ID: 30409995
[TBL] [Abstract][Full Text] [Related]
17. CCN1 promotes the differentiation of endothelial progenitor cells and reendothelialization in the early phase after vascular injury.
Yu Y; Gao Y; Qin J; Kuang CY; Song MB; Yu SY; Cui B; Chen JF; Huang L
Basic Res Cardiol; 2010 Nov; 105(6):713-24. PubMed ID: 20830586
[TBL] [Abstract][Full Text] [Related]
18. Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response.
Feng P; Wang B; Ren EC
Int J Biochem Cell Biol; 2008; 40(1):98-109. PubMed ID: 17698398
[TBL] [Abstract][Full Text] [Related]
19. Cyr61/CCN1 induces CCL20 production by keratinocyte via activating p38 and JNK/AP-1 pathway in psoriasis.
Li H; Li H; Huo R; Wu P; Shen Z; Xu H; Shen B; Li N
J Dermatol Sci; 2017 Oct; 88(1):46-56. PubMed ID: 28602508
[TBL] [Abstract][Full Text] [Related]
20. CCN1/Cyr61-PI3K/AKT signaling promotes retinal neovascularization in oxygen-induced retinopathy.
Di Y; Zhang Y; Nie Q; Chen X
Int J Mol Med; 2015 Dec; 36(6):1507-18. PubMed ID: 26459773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
